TYMP and gastric cancer: This study was designed to demonstrate the clinical implications of TP and TUBB3 expressions in capecitabine plus paclitaxel chemotherapy for advanced gastric cancer patients, and to identify potential predictors for patients with gastric cancer treated with capecitabine plus paclitaxel.